BIGT vs. UKRE ETF Comparison
Comparison of L&G Pharma Breakthrough UCITS ETF (BIGT) to iShares MSCI Target UK Real Estate UCITS ETF (UKRE)
BIGT
L&G Pharma Breakthrough UCITS ETF
BIGT Description
The objective of the fund is to provide exposure to a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The Index selects stocks that meet certain size and liquidity requirements using a two-fold approach that is primarily based on the trend in the valuation of a companyâs orphan drug portfolio and its overall revenue forecasts.
Grade (RS Rating)
Last Trade
£727.45
Average Daily Volume
2,823
Number of Holdings
*
8
* may have additional holdings in another (foreign) market
UKRE
iShares MSCI Target UK Real Estate UCITS ETF
UKRE Description
The Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Fund¡¯s assets, which reflects the return of the MSCI UK IMI Liquid Real Estate Index, the Fund¡¯s benchmark index (Index).Grade (RS Rating)
Last Trade
£396.80
Average Daily Volume
64,504
Number of Holdings
*
29
* may have additional holdings in another (foreign) market
Performance
Period | BIGT | UKRE |
---|---|---|
30 Days | -5.88% | -1.35% |
60 Days | -6.52% | -1.50% |
90 Days | -8.45% | -0.41% |
12 Months | -22.58% | -4.61% |
0 Overlapping Holdings
Symbol | Grade | Weight in BIGT | Weight in UKRE | Overlap |
---|
BIGT Underweight 29 Positions Relative to UKRE
Symbol | Grade | Weight | |
---|---|---|---|
SGRO | D | -10.91% | |
LMP | B | -5.59% | |
LAND | D | -4.87% | |
UTG | D | -3.72% | |
BLND | B | -3.39% | |
BBOX | D | -3.11% | |
GRI | D | -2.47% | |
BYG | B | -2.43% | |
DLN | C | -2.34% | |
PHP | F | -2.12% | |
AGR | F | -1.95% | |
SAFE | D | -1.66% | |
SRE | B | -1.03% | |
SUPR | F | -1.02% | |
ESP | D | -0.91% | |
GPE | B | -0.85% | |
CREI | C | -0.69% | |
IWG | D | -0.69% | |
THRL | D | -0.68% | |
IHR | C | -0.68% | |
UKCM | C | -0.63% | |
WKP | F | -0.52% | |
SHED | F | -0.52% | |
BCPT | B | -0.49% | |
PRSR | D | -0.46% | |
PCTN | C | -0.45% | |
HMSO | A | -0.33% | |
WHR | F | -0.31% | |
CLI | F | -0.12% |
BIGT: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Keywords:
Biopharmaceutical
Drugs
Medical Specialties
Organ Systems
Rare Diseases
Alzheimer's Disease
Duchenne Muscular Dystrophy
Follicular Lymphoma
Gene Therapy
Immunosuppressants
Medicine
Monoclonal Antibodies
Multiple Sclerosis
Muscular Dystrophy
Neuroscience
Orphan Drugs
Plaque Psoriasis
Smallpox
Vaccination
Vaccines
UKRE: Top Represented Industries & Keywords